Recombinant Activated Factor VIIa Treatment for Refractory Hemorrhage in Infants

OBJECTIVE: Report clinical response to recombinant factor VIIa in a cohort of critically ill infants. STUDY DESIGN: We identified all infants who received factor VIIa in the Duke Neonatal Intensive Care Unit between January 2005 and July 2008. Hematologic data and volume of blood transfusions before...

Descripción completa

Detalles Bibliográficos
Autores principales: Dang, Chi N, Katakam, Lakshmi I, Smith, P Brian, Cotten, C Michael, Goldberg, Ronald N, Chandler, Nicole, Thornburg, Courtney D, Bidegain, Margarita
Formato: Texto
Lenguaje:English
Publicado: 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972386/
https://www.ncbi.nlm.nih.gov/pubmed/20671714
http://dx.doi.org/10.1038/jp.2010.85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972386/
https://www.ncbi.nlm.nih.gov/pubmed/20671714
http://dx.doi.org/10.1038/jp.2010.85

Ejemplares similares